Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
Go back to Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.55 -0.25 (3.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.80 | 52 Week High | $44.38 | |||
| Open | $6.80 | 52 Week Low | $24.47 | |||
| Day High | $6.90 | P/E | 327.50 | |||
| Day Low | $6.48 | EPS | $0.02 | |||
| Volume | 1,512,571 | |||||
